Gilead Canada Grants Program

Gilead welcomes funding requests for innovative, high-impact projects that relate to at least one of the following core therapeutic areas:

• HIV
• Liver disease
• HCV
• HBV
• HDV
• Primary Biliary Cholangitis
• Oncology/Hematology/Solid Tumors

We consider several factors when reviewing grant requests, but it is most important for applications to demonstrate a strong commitment to — and capacity for — delivering the specific outcomes the funded grant would support.

HIV

Our mission is to build on decades of groundbreaking scientific advances, community collaboration, and public health advocacy to continue transforming the landscape of HIV care. While significant progress has been made, the fight against HIV is ongoing. With six Canadians still dying of HIV-related illnesses and 35 more being diagnosed each week, we remain committed to pushing the boundaries of innovation and partnership. By partnering with communities, we aim to help achieve UNAIDS targets and drive meaningful progress in ending the HIV epidemic for everyone, everywhere.

We are seeking to support projects that focus on Awareness, Advocacy, Education, Research, or Service Delivery. Specifically, we are interested in initiatives that address critical gaps in the HIV care cascade, particularly those that aim to link 95% of people living with HIV (PLWH) to care or that promote access to HIV prevention. Additionally, projects should demonstrate a commitment to advancing health equity and must target priority populations such as gay, bisexual, and men who have sex with men (GBMSM), migrants, racialized communities, and Indigenous groups.

Liver Disease

To help advance Canada’s efforts of reaching the World Health Organization’s HCV elimination goals by 2030, Gilead supports screening and linkage-to-care (SLTC) projects through its grants program with the objective of addressing gaps and re-igniting SLTC initiatives that help patients in priority settings and populations.

Specific areas of interest for HCV projects include:

• Implementation or improvement of models that facilitate linkage to and retention in care (including new testing approaches or settings)
• Interventions or activities that simplify and strengthen the patient journey to improve the care cascade

Oncology, Hematology, and Solid Tumors

We welcome a diverse range of funding applications in the cancer space, including patient and policy advocacy efforts to improve health outcomes for Canadians, patient education materials, disease awareness campaigns, and other innovative ways to partner with difficult to reach communities.

We provide funding in two categories:

• Patient community support
• Medical and scientific support

Grant applications are accepted throughout the year.

Apply for Grant Funding Now

Contact us at [email protected].